Conduit Pharmaceuticals

CDTNASDAQ
$0.272100
-0.02-6.17%
Last update: 2:31 PM
15 minutes delayed

Conduit Pharmaceuticals (NASDAQ:CDT) Stock, Earnings Estimates, EPS, And Revenue

Conduit Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 14
EPS
$-0.050
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)

Analyze the earnings history of Conduit Pharmaceuticals using advanced sorting and filters.

Get Alert
CDT
Conduit Pharmaceuticals
08/13/2024Get Alert
CDT
Conduit Pharmaceuticals
-$0.03-$0.05$0.00$0.0005/14/2024Get Alert
CDT
Conduit Pharmaceuticals
-$0.03-$0.02$0.00$0.0002/16/2024Get Alert
CDT
Conduit Pharmaceuticals
-$0.03$0.00$0.00$0.0011/20/2023Get Alert

Conduit Pharmaceuticals (CDT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %

Conduit Pharmaceuticals (CDT) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Conduit Pharmaceuticals (NASDAQ:CDT) reporting earnings?

A

Conduit Pharmaceuticals (CDT) is scheduled to report earnings on August 13, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Conduit Pharmaceuticals (NASDAQ:CDT)?

A

The Actual EPS was $-0.05, which missed the estimate of $0.00.

Q

What were Conduit Pharmaceuticals’s (NASDAQ:CDT) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch